Laura Ferris, MD, PhD
Laura Korb Ferris, MD, PhD is an Associate Professor and Director of Clinical Trials at the University of Pittsburgh Department of Dermatology. She is a member of the University of Pittsburgh Cancer Institute melanoma program where directs the pigmented lesions clinic. Dr. Ferris has been an investigator on several clinical trials evaluating technologies and assays for melanoma early detection and predictors of outcome in patients with melanoma. Her research, which is primarily focused on melanoma epidemiology, screening, and early detection has been widely published in the peer-reviewed literature. Dr. Ferris received her PhD in immunology from The Johns Hopkins School of Medicine and her MD from The University of Maryland and she completed her residency in dermatology and fellowship in cutaneous oncology at the University of Pittsburgh.
Pedram Gerami, MD
Pedram Gerami is an associate professor of dermatology and pediatrics at Northwestern University and the co-director of melanoma research at the Northwestern Skin Cancer Institute. Dr Gerami is interested in the clinical, histologic and molecular genetics of melanocytic neoplasms. As a clinical dermatologist he sees patients with a history of melanoma or dysplastic nevi and as a dermatopathologist he is focused in the histopathologic evaluation of melanocytic neoplasms. He has authored over 80 peer reviewed journal articles and numerous chapters in dermatologic textbooks. His research is primarily focused on the use of molecular diagnostics to improve diagnosis and prognostication of melanocytic neoplasms. Dr Gerami received his medical degree from the Chicago Medical School and received his residency at the University of Iowa Department of Dermatology followed by a fellowship in dermatopathology at the University of Chicago.